RETINALGENIX TECHNOLOGIES INC.: 10-Q filed 2024-05-20

Name: RETINALGENIX TECHNOLOGIES INC.: 10-Q filed 2024-05-20
Creator: RETINALGENIX TECHNOLOGIES INC.

What RETINALGENIX TECHNOLOGIES INC. reported in its quarterly report filed 2024-05-20 (fiscal Q1 2024): 21 published measures, 44 facts as tagged in accession 0001493152-24-020564.

This filing

Form: 10-Q (quarterly report)
Filed: 2024-05-20
Fiscal period: fiscal Q1 2024
Accession: 0001493152-24-020564 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All RETINALGENIX TECHNOLOGIES INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2024-03-31	50,517	USD
At 2023-12-31	156	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2024-03-31	1,569,346	USD
At 2023-12-31	1,405,813	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2024-03-31	-1,518,829	USD
At 2023-12-31	-1,405,657	USD
At 2022-12-31	-1,069,063	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	-2,145,876	USD	91
2023-01-01 to 2023-12-31	-2,090,889	USD	365
2023-01-01 to 2023-03-31	-510,643	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	-142,869	USD	91
2023-01-01 to 2023-03-31	-77,575	USD	90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	193,255	USD	91
2023-01-01 to 2023-03-31	85,007	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2024-03-31	-13,255,071	USD
At 2023-12-31	-11,109,195	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	17,672,145	shares	91
2023-01-01 to 2023-03-31	17,272,116	shares	90

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	17,672,145	shares	91
2023-01-01 to 2023-03-31	17,272,116	shares	90

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	-0.12	USD/shares	91
2023-01-01 to 2023-03-31	-0.03	USD/shares	90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	-0.12	USD/shares	91
2023-01-01 to 2023-03-31	-0.03	USD/shares	90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2024-03-31	131	USD
At 2023-12-31	156	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	1,732,834	USD	91
2023-01-01 to 2023-03-31	78,509	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2024-03-31	50,386	USD
At 2023-12-31	0	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	960	USD	91
2023-01-01 to 2023-03-31	960	USD	90

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	2,144,916	USD	91
2023-01-01 to 2023-03-31	509,683	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2024-03-31	17,860,478	shares
At 2023-12-31	17,635,478	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2024-03-31	11,734,456	USD
At 2023-12-31	9,701,774	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2024-03-31	176	USD
At 2023-12-31	151	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	328,985	USD	91
2023-01-01 to 2023-03-31	203,242	USD	90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2024-01-01 to 2024-03-31	25	USD	91
2023-01-01 to 2023-03-31	25	USD	90

Inspect the source

Entity: RETINALGENIX TECHNOLOGIES INC. / CIK 0001836295
Captured: 2026-09-21T17:29:46.648Z
SEC response SHA-256: dd1391ce51bf49d231e305a3aac122a3dd931e6d5a5195ef8432fe80b7fd24ad

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001836295.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))